Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Xpert® Xpress CoV-2 plus (XPRS-COV2-10)

K-Number: K242109 · 2025-01-15

ApplicantCepheid®
Decision Date2025-01-15
Product CodeQQX
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

Xpert® Xpress CoV-2 plus (XPRS-COV2-10) is a medical device manufactured by Cepheid®. It received FDA 510(k) clearance on 2025-01-15 under approval number K242109. The device is classified under product code QQX. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Xpert® Xpress CoV-2 plus (XPRS-COV2-10)?

Xpert® Xpress CoV-2 plus (XPRS-COV2-10) is a medical device that received FDA 510(k) clearance on 2025-01-15. It is manufactured by Cepheid®. The 510(k) number is K242109.

When was Xpert® Xpress CoV-2 plus (XPRS-COV2-10) approved by the FDA?

Xpert® Xpress CoV-2 plus (XPRS-COV2-10) received FDA 510(k) clearance on 2025-01-15, under approval number K242109.

What company makes Xpert® Xpress CoV-2 plus (XPRS-COV2-10)?

Xpert® Xpress CoV-2 plus (XPRS-COV2-10) is manufactured by Cepheid®.

What is the FDA product code for Xpert® Xpress CoV-2 plus (XPRS-COV2-10)?

The FDA product code for Xpert® Xpress CoV-2 plus (XPRS-COV2-10) is QQX.

Other Devices by Cepheid®

View all 10 devices →

Related Devices (Code: QQX)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.